Vanderbilt Heart and Vascular Institute (VHVI)
-
February 19, 2015
Vitamin D found to have no impact on blood pressure
Despite prior epidemiologic and experimental data to the contrary, new research shows that vitamin D supplementation does not reduce blood pressure in individuals with prehypertension or stage I hypertension and vitamin D deficiency. -
February 5, 2015
Study to explore myeloma treatment’s impact on heart
Vanderbilt is embarking on an observational study to define and understand how a promising treatment for multiple myeloma affects the heart. -
October 16, 2014
Heart patient uses ICD experience to promote benefits of exercise
Carrie Romero of Columbia, Tennessee, is running for her life. In 1997, when she was 28, Romero was diagnosed with dilated cardiomyopathy — a heart muscle disease that puts her at risk for sudden cardiac arrest (SCA). -
October 9, 2014
Heart Institute celebrates implantation program success
Vanderbilt Heart and Vascular Institute (VHVI) reached a significant milestone recently with the 100th implantation of the miniaturized HeartWare HVAD Pump, a left ventricular assist device (LVAD) that supports the heart. -
October 2, 2014
VHVI screening brings heart care to young athletes
Vanderbilt Heart and Vascular Institute (VHVI) recently hosted a cardiovascular health screening for participants in a nonprofit organization called the Enplay Foundation, for middle and high school athletes and their adult family members. -
September 25, 2014
Churchwell to depart VHVI; Clair to assume interim role
Keith Churchwell, M.D., executive director and chief medical officer for the Vanderbilt Heart and Vascular Institute (VHVI), is departing Vanderbilt and will join Yale-New Haven Health System as vice president and executive director of Cardiovascular Services on Dec. 1. -
September 18, 2014
Heart Institute testing world’s tiniest pacemaker
Vanderbilt Heart and Vascular Institute is participating in a global clinical trial to test the safety and efficacy of the world’s smallest pacemaker.